Quince Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for QNCX, updated each market day.
QNCX AI Sentiment
AI predicts Quince Therapeutics, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Quince Therapeutics, Inc. Common Stock
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
Sector
Exchange
Market Cap
$6,887,800
Cap Tier
Employees
36
Headquarters
SOUTH SAN FRANCISCO, CA
Listed Since
May 9, 2019
Website
QNCX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
QNCX Volatility
Quince Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
